Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells
Agnieszka Korga-Plewko(Medical University of Lublin), Jarosław Dudka(Medical University of Lublin), Magdalena Iwan(Medical University of Lublin), Rafał Wójcik(Medical University of Lublin), Mariola Herbet(Medical University of Lublin), Marta Ostrowska-Leśko(Medical University of Lublin), Gemma Gomez Vilarrubla(Medical University of Lublin), Grażyna Zgórka(Medical University of Lublin), Aleksandra Józefczyk(Medical University of Lublin)
Cited by 61
Related Papers
HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation
|Brain Sciences|2021|399
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
|International Journal of Molecular Sciences|2023|327
Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatment
|FEBS Open Bio|2019|50
The effect of a number of H9C2 rat cardiomyocytes passage on repeatability of cytotoxicity study results
|Cytotechnology|2016|48
The Role of Molecular and Inflammatory Indicators in the Assessment of Cognitive Dysfunction in a Mouse Model of Diabetes
|International Journal of Molecular Sciences|2021|43